These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1779726)

  • 1. Mn[III] uroporphyrin I: a novel metalloporphyrin contrast agent for magnetic resonance imaging.
    McMillan JH; Cox GG; Kimler BF; Spicer JS; Batnitzky S
    Magn Reson Imaging; 1991; 9(4):553-8. PubMed ID: 1779726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 snapshot FLASH measurement of rat brain glioma: kinetics of the tumor-enhancing contrast agent manganese (III) tetraphenylporphine sulfonate.
    Hoehn-Berlage M; Norris D; Bockhorst K; Ernestus RI; Kloiber O; Bonnekoh P; Leibfritz D; Hossmann KA
    Magn Reson Med; 1992 Oct; 27(2):201-13. PubMed ID: 1461108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor specific contrast enhancement study of Mn-metalloporphyrin (ATN-10)--comparison of rat brain tumor model, cytotoxic and vasogenic edema models.
    Fujimori H; Matsumura A; Yamamoto T; Shibata Y; Yoshizawa T; Nakagawa K; Yoshii Y; Nose T; Sakata I; Nakajima S
    Acta Neurochir Suppl; 1997; 70():167-9. PubMed ID: 9416311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors.
    Yamamoto T; Matsumura A; Shibata Y; Fujimori H; Nakai K; Yoshida F; Nose T; Sakata I; Nakajima S; Miwa N
    Neurosurgery; 1998 Jun; 42(6):1332-7; discussion 1337-8. PubMed ID: 9632193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo relaxometry of three brain tumors in the rat: effect of Mn-TPPS, a tumor-selective contrast agent.
    Wilmes LJ; Hoehn-Berlage M; Els T; Bockhorst K; Eis M; Bonnekoh P; Hossmann KA
    J Magn Reson Imaging; 1993; 3(1):5-12. PubMed ID: 8428101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS.
    Ernestus RI; Wilmes LJ; Hoehn-Berlage M
    Clin Exp Metastasis; 1992 Sep; 10(5):345-50. PubMed ID: 1505124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
    Pickup S; Chawla S; Poptani H
    Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI contrast enhancement by MnTPPS of experimental brain tumours in rats.
    Bockhorst K; Hoehn-Berlage M; Kocher M; Hossmann KA
    Acta Neurochir Suppl (Wien); 1990; 51():134-6. PubMed ID: 2089878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
    Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Weber M; Stadlbauer A; Grabner G; Knosp E; Trattnig S
    Neuroradiology; 2008 Jan; 50(1):9-16. PubMed ID: 17876570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.
    Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R
    J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
    Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
    Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla.
    Biswas J; Nelson CB; Runge VM; Wintersperger BJ; Baumann SS; Jackson CB; Patel T
    Invest Radiol; 2005 Dec; 40(12):792-7. PubMed ID: 16304483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I
    Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton relaxation enhancement in experimental brain tumors--in vivo NMR study of manganese(III)TPPS in rat brain gliomas.
    Bockhorst K; Höhn-Berlage M; Kocher M; Hossmann KA
    Magn Reson Imaging; 1990; 8(4):499-504. PubMed ID: 2392036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.